Make any changes to a patients insulin regimen under close medical supervision with increased frequency of blood glucose monitoring
American gastroenterological association clinical practice update: management of pancreatic necrosis
Recent studies have shown that GLP-1 use is associated with a reduction in cases of dementia among people with type 2 diabetes (something that's likely to also be true in a broader population of people at risk for dementia)
For TB-500: Malinda et al
Benefits: Helps reduce triglyceride levels by up to 40%, supports cardiovascular health, mitigates inflammatory responses, and contributes to healthy aging by protecting cells from oxidative stress
The presence or absence of nausea, vomiting, or diarrhea does not determine weight loss success, and the medication remains highly effective even in users who experience minimal to no gastrointestinal symptoms